Latest News
Child Psychiatry Consult
Remodeling broken systems
Meaningful improvement in children’s mental health will require remodeling broken systems to ensure that children are supported early, effectively...
Feature
12 steps to closing your practice without problems
“Many don’t think about compliance issues, patient abandonment, or accounts receivable that they need to keep open to collect from billing, which...
From the Journals
Minimally invasive surfactant shows some benefit in infants’ first 2 years
MIST, compared with sham treatment, did not reduce death or neurodevelopmental disability, but infants who received MIST had lower rates of poor...
News from the FDA/CDC
FDA panel deems phenylephrine ineffective
The committee’s next move is to determine if the drug’s status as Generally Recognized as Safe and Effective should be revoked.
Latest News
Company submits supplemental NDA for topical atopic dermatitis treatment
The development is based on results from two identical phase 3, vehicle-controlled trials.
Latest News
New COVID vaccines force bivalents out
The updated mRNA vaccines for 2023-2024 are being revised to include a single component that corresponds to the Omicron variant XBB.1.5.
Letters from Maine
Willpower and obesity
As effective obesity drugs become more available and remain safe, it is likely that willpower will no longer dominate the populous psyche.
Latest News
Seeking help for burnout may be a gamble for doctors
Disclosing burnout resulting in being “ostracized, penalized, and ultimately ousted,” is the rule rather than the exception.
From the Journals
Nurses maintain more stigma toward pregnant women with OUD
Clinical experience and training may affect differences in attitudes toward women who use opioids during pregnancy.
Latest News
RSV season has started, and this year could be different
Typically, the CDC considers the start of RSV season to occur when the rate of positive tests for the virus goes above 3% for 2 consecutive weeks...
Latest News
New Moderna vaccine to work against recent COVID variant
The FDA is expected to approve the new Moderna shot by early October.